SKYVaricella Injection Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Live attenuated varicella-zoster virus (Oka/SK strain) ≥2,400 PFU

Indications/Uses

Prevention of varicella in childn 12 mth to 12 yr.

Click to view SKYVaricella Injection detailed prescribing information

Dosage/Direction for Use

SC Inj 0.5 mL in deltoid region. 1st dose: Administer at 12-18 mth. 2nd dose: Administer at 4-6 yr. Varicella outbreak May administer 2nd dose before 4 yr but w/ at least 3 mth interval from 1st dose.

Click to view SKYVaricella Injection detailed prescribing information

Contraindications

Hypersensitivity to gelatin or any other component of vaccine. History of anaphylactic/anaphylactoid reaction to neomycin. Primary & acquired immunodeficiency states due to acute & chronic leukemias, lymphoma, other conditions affecting bone marrow or lymphatic system, HIV/AIDS & cellular immune deficiencies. Immunosuppressive therapy. Active untreated TB; febrile resp disease or infections. Women of childbearing potential. Pregnancy.

Click to view SKYVaricella Injection detailed prescribing information

Special Precautions

Anaphylactic/anaphylactoid reaction might occur. Defer vaccination in the presence of acute illness eg, fever >38°C. Reye's syndrome. Avoid close association w/ high-risk individuals eg, immunocompromised, pregnant women & newborn infants of mothers w/o documented history of chickenpox or lab evidence of prior infection for up to 6 wk following vaccination. Provide adequate treatment provisions including epinephrine inj (1:1000) for immediate use. Use w/in min interval of 3-11 mth after blood or plasma transfusion or Ig or varicella-zoster Ig administration. Avoid use of salicylates for 6 wk post-vaccination. Not to be given w/ Ig including varicella-zoster Ig concomitantly or 2 mth thereafter. Avoid pregnancy for 3 mth following vaccination. Not to be used during pregnancy. Nursing mothers. Not recommended in infant <12 mth. Not to be used in adults including elderly.

Click to view SKYVaricella Injection detailed prescribing information

Use In Pregnancy & Lactation

Click to view SKYVaricella Injection detailed prescribing information

Adverse Reactions

Pain/tenderness, erythema/redness, induration/swelling; fever, somnolence/exhaustion, headache, whining/irritability, fatigue/malaise. Skin & SC tissue disorders, infections & infestations.

Click to view SKYVaricella Injection detailed prescribing information

Drug Interactions

Concomitant use w/ salicylates; Ig or varicella-zoster Ig transfusion.

Click to view SKYVaricella Injection detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view SKYVaricella Injection detailed prescribing information

Storage

View SKYVaricella Injection storage conditions for details to ensure optimal shelf-life.

Description

View SKYVaricella Injection description for details of the chemical structure and excipients (inactive components).

Action

View SKYVaricella Injection mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BK01 - varicella, live attenuated ; Belongs to the class of varicella viral vaccines.

Thai FDA Category

Presentation/Packing

Form

SKYVaricella Injection vaccine inj

Packing/Price

((lyo)) 5 × 1's

SKYVaricella Injection

varicella-zoster vaccine

Manufacturer:

SK Bioscience

Distributor:

Biogenetech

Marketer:

Bionovel